InvestorsHub Logo
Followers 8
Posts 6947
Boards Moderated 0
Alias Born 07/31/2006

Re: AxiomOne post# 5005

Wednesday, 09/26/2007 3:22:32 PM

Wednesday, September 26, 2007 3:22:32 PM

Post# of 14825
AXIOM INTERESTING THAT ONCE THE DISTRIBUTOR GOT CALYPTE APPROVED IN INDIA THAT CALYPTE'S RESPONSE WAS TO DUMP THE DISTRIBUTOR FOR A BIGGER AND BETTER DISTRIBUTOR. REALLY CONFIDENCE INSPIRING TO DEAL WITH CALYPTE ISN'T IT.

IN ADDITION IT APPEARS THERE IS TROUBLE IN RUSSIA. RAPID ORAL APPROVED IN RUSSIA BUT RUSSIA WON'T LET THEM SELL IT? WHAT DOES THAT MEAN?

ALSO

ROGER SAID THAT THE USAID APPROVAL WAS THE FIRST TIME THEY HAD ACCESS TO FUNDS FROM USAID. DID HE FORGET THAT THE RAPID BLOOD TEST HAS BEEN ON THE USAID approved LIST FOR OVER A YEAR. APPARENTLY SO.

Good News is that this interview only cost Calypte $ 280. Much better than the amount they pay CEOcast for their "coverage".

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.